WORLDWIDE CONTACT US ABOUT US INVENTING FOR LIFE PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home WORLD SLEEP DAY World Sleep Day takes place on Friday, March 17, and is intended to be a celebration of sleep and a call to action on important issues related to sleep around the world. Organized by the World Sleep Society, the theme of this year's 10th annual event is "Sleep Soundly, Nurture Life," which recognizes the importance of sleep for overall health. Prior to World Sleep Day, most Americans will lose one hour of sleep as a result of Daylight Saving Time. Most people can handle the time change without difficulty, but for the millions of Americans struggling with insomnia, sleep is an ongoing issue. YOU'RE NOT ALONE Insomnia is typically characterized by trouble falling or staying asleep, and can affect people in a variety of ways. 23.5 MILLION 10% Insomnia can be a frustrating, and even isolating condition, yet in the U. S., an estimated 23.5 MILLION PEOPLE experience symptoms consistent with the diagnosis of insomnia – roughly 10 PERCENT of the adult population. HEAR WHAT IT'S LIKE FOR OTHER INSOMNIA SUFFERERS WHEN THEY CAN'T SLEEP LEARN MORE Merck provides a number of resources to help patients struggling with sleep manage their condition. If you think you may be suffering from insomnia, be sure to check out these links and learn more about how to get the sleep you need. Published March 2017 Copyright. © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map

WORLDWIDE CONTACT US ABOUT US INVENTING FOR LIFE PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home MERCK’S SUSAN SHIFF SELECTED AS ONE OF 15 FIERCE WOMEN IN BIOPHARMA 2016 “Ultimately, our goal is to help patients get access to the health care they need in an affordable, effective, and efficient way.” - Susan Shiff, senior vice president and head of Merck’s Center for Observational and Real-World Evidence (CORE) Since she joined Merck in 2014, Susan Shiff has been leading CORE, the arm of our company that harnesses “real-world” data to provide the best available information on the value of the medicines and vaccines that we bring to the market. For this cutting-edge work, she’s been selected as one of 15 Fierce Women in Biopharma 2016, which honors women who are standing out in the biopharma industry. (Read her profile on FiercePharma.) Susan sees CORE’s work as immeasurably beneficial for Merck and the health care system as a whole. “If we can understand which therapies benefit our patients the most, the impact on the health care system could be enormous,” she notes. Published October 2016 Copyright. © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map